Phathom Pharmaceuticals, Inc. (PHAT) total debt

Total debt · fiscal 2025
$211.80M

Phathom Pharmaceuticals, Inc. (PHAT) carried total debt of $211.80M at the end of fiscal 2025 (December 31, 2025). That is 4.9% higher than the $201.91M of fiscal 2024. Figures as of 18 Nov 2026, 13:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$211.80M
Change on fiscal 2024
+4.9%
Growth, 5 years
+35.1% a year
Highest on record
$211.80Mfiscal 2025
Lowest on record
$22.78Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Phathom Pharmaceuticals, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 35.1% a year. Across the 7 fiscal years on record (2019–2025), the highest was $211.80M in fiscal 2025 and the lowest $22.78M in fiscal 2019.

History · 7 fiscal years

Total debt by fiscal year

Phathom Pharmaceuticals, Inc. total debt, year by year

Phathom Pharmaceuticals, Inc. (PHAT) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$211.80M 4.9% up—
2024$201.91M 45.2% up—
2023$139.03M 43.2% up—
2022$97.07M 8.3% up—
2021$89.67M 90.8% up1.2×
2020$46.99M 106.3% up0.2×
2019$22.78M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on PHAT

Phathom Pharmaceuticals, Inc., figure by figure

Phathom Pharmaceuticals, Inc. (PHAT) overview: price, valuation and scorecard

Phathom Pharmaceuticals, Inc. total debt: questions and answers

How much debt does Phathom Pharmaceuticals, Inc. have?

Phathom Pharmaceuticals, Inc. (PHAT) carried total debt of $211.80M at the end of fiscal 2025 (December 31, 2025). That is 4.9% higher than the $201.91M of fiscal 2024.

What is the growth rate of Phathom Pharmaceuticals, Inc.'s total debt?

Over the five fiscal years to 2025 total debt grew at a compound 35.1% a year.

What are the highest and lowest total debt figures on record for Phathom Pharmaceuticals, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $211.80M in fiscal 2025 and the lowest $22.78M in fiscal 2019.

How is Phathom Pharmaceuticals, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Phathom Pharmaceuticals, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Phathom Pharmaceuticals, Inc. (PHAT) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PHAT/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.